AG Leiter: Assoc. Prof. PD Dr. Martin Bodingbauer
AG Leiter: Medizinische Universität Wien
Universitätsklinik für Chirurgie
Währinger Gürtel 18-20
1090 Wien
Tel: +43-1-40400-56210
Fax: +43-1-40400-56410
Email: martin.bodingbauer@meduniwien.ac.at
Stellvertreter:
OA Dr. Helwig Wundsam
helwig.wundsam@Âordensklinikum.at
Aktuelles aus der Arbeitsgruppe
Literaturhinweise
18. 02.2020- Laparoscopic Versus Open Thermal Ablation of Colorectal Liver Metastases: A Propensity Score-Based Analysis of Local Control of the Ablated Tumors.
- Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC) – a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)- the AIO/ CALGP/ ACO- GAIN-trial.
- The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.
- Safety margin assessment after microwave ablation of liver tumors: inter- and intrareader variability.
- Clinical Outcomes of Stereotactic Body Radiation Therapy for Small Hepatocellular Carcinoma.
- Prognostic significance of and risk prediction model for lymph node metastasis in resectable intrahepatic cholangiocarcinoma: do all require lymph node dissection?
- Effect of surgical margin width after R0 resection for intrahepatic cholangiocarcinoma: A nationwide survey of the Liver Cancer Study Group of Japan.
- Prospective double-blinded randomized controlled trial of Microwave versus RadioFrequency Ablation for hepatocellular carcinoma (McRFA trial).
- Robotic right hepatectomy for a central liver tumor- A video of the surgical technique.
Literaturhinweise
7. 01.2020- Prognostic role of preoperative albumin-bilirubin grade on patients with hepatocellular carcinoma after surgical resection: a systematic review and meta-analysis.
- Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma.
- Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer.
- Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasis.
- Laparoscopic versus open limited liver resection for hepatocellular carcinoma with liver cirrhosis: a propensity score matching study with the Hiroshima Surgical study group of Clinical Oncology (HiSCO).
- Long term recurrence free survival in a stage IV gallbladder cancer treated with chemotherapy plus trastuzumab and salvage liver resection.
- Comparison of the clinical results of surgical resection for extrahepatic cholangiocarcinomas: Hilar cholangiocarcinoma and mid-to-distal cholangiocarcinoma.
- Repeat liver resection versus salvage liver transplant for recurrent hepatocellular carcinoma: A propensity score-adjusted and -matched comparison analysis.
- Intraoperative radiofrequency ablation and distilled water peritoneal lavage for spontaneously ruptured hepatocellular carcinoma.
- Simultaneous resection of the primary tumour and liver metastases after conversion chemotherapy versus standard therapy in pancreatic cancer with liver oligometastasis: protocol of a multicentre, prospective, randomised phase III control trial (CSPAC-1).
- Cholecystitis and risk of pancreatic, liver, and biliary tract cancer in patients undergoing cholecystectomy.
Literaturhinweise
3. 12.2019- Ischemic Cholangiopathy Following Transcatheter Arterial Chemoembolization for Recurrent Hepatocellular Carcinoma After Hepatectomy: an Underestimated and Devastating Complication.
- Long-Term and Oncologic Outcomes of Robotic Versus Laparoscopic Liver Resection for Metastatic Colorectal Cancer: A Multicenter, Propensity Score Matching Analysis.
- Hepatic resection after neoadjuvant chemotherapy for patients with liver metastases from colorectal cancer: need for cautious planning.
- Histological tumor response assessment in colorectal liver metastases after neoadjuvant chemotherapy: impact of the variation in tumor regression grading and peritumoral lymphocytic infiltration.
- Liver microwave ablation: a systematic review of various FDA-approved systems.
- Liver Resection Is Justified in Patients with BCLC Intermediate Stage Hepatocellular Carcinoma without Microvascular Invasion.
- Locoregional Therapy, Immunotherapy and the Combination in Hepatocellular Carcinoma: Future Directions.
- Robotic hepatic surgery in malignancy: review of the current literature.
- Hamartomas and malformations of the liver.